Related Experiment Videos

Biochemical scores could reflect histological activity in chronic hepatitis C

R Testa1, A Picciotto, G Lapertosa

  • 1Dipartimento di Medicina Interna, Università di Genova, Italy.

The Italian Journal of Gastroenterology
|December 1, 1994
PubMed

Insights

This study developed a Biochemical Activity Index (BAI) using liver tests to assess chronic active hepatitis (CAH) activity. The BAI effectively differentiates between moderate and severe CAH, offering a non-invasive method for monitoring liver disease progression.

Area of Science:

  • Hepatology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Chronic active hepatitis (CAH) is a significant liver condition.
  • Accurate assessment of liver disease activity is crucial for patient management.
  • Histological Activity Index (HAI) is a standard but invasive method for grading liver disease.

Purpose of the Study:

  • To correlate liver function tests with the histological activity index (HAI) in patients with Hepatitis C Virus (HCV)-positive CAH.
  • To develop and validate a Biochemical Activity Index (BAI) for assessing liver disease activity.
  • To establish a non-invasive method for monitoring the severity of chronic liver disease.

Main Methods:

  • Multivariate regression analysis was employed to correlate liver tests with HAI in 81 HCV-positive CAH patients.
  • Patients were divided into moderate and severe CAH groups based on median HAI values.
  • Backward stepwise analysis identified key biochemical parameters (ALT, gammaglobulins, gammaglutamyl transpeptidase, prolyl-hydroxylase) for the BAI.

Main Results:

  • Multiple regression analysis enhanced the significance of nine biochemical parameters related to HAI.
  • A combination of ALT, gammaglobulins, gammaglutamyl transpeptidase, and prolyl-hydroxylase showed the best correlation with HAI (R = 0.520, p < 0.0001).
  • The derived BAI demonstrated a significant difference between moderate (7.7 +/- 1.3) and severe (12.2 +/- 2) CAH (p < 0.0001).

Conclusions:

  • The developed BAI serves as a reliable indicator for assessing the activity of chronic liver diseases.
  • This biochemical index offers a potentially non-invasive alternative to liver biopsy for monitoring disease progression.
  • The BAI can aid clinicians in better managing patients with chronic hepatitis C.

Related Concept Videos